Respiratory Care Diagnostic devices are the devices which
are used for the diagnosis of respiratory diseases such as Pneumonia, Asthma,
Bronchitis, Sleep Apnea, cystic and pulmonary fibrosis, Tuberculosis, COPD
(Chronic Obstructive Pulmonary Disease) etc. The Respiratory Care Device global
market is segmented based on the products, applications, end-users and
geography. Products are divided into Therapeutic device, Monitoring Device,
Diagnostic Device and Consumables.
Complete report details @ https://www.wiseguyreports.com/reports/591163-respiratory-care-devices-global-market-forecast-to-2022
Therapeutic devices include humidifiers, nebulizers, oxygen
concentrators, Positive airway pressure (PAP) device, resuscitators,
ventilators, inhalers and others. Humidifiers are further segmented into
passive and active humidifiers. Nebulizers are segmented into jet nebulizers,
ultrasonic nebulizers, mesh nebulizers and smart nebulizers. Oxygen
concentrators are divided into stationary oxygen concentrators and portable
oxygen concentrators. Positive airway pressure devices are further segmented
such as continuous positive airway pressure (CPAP) devices, Automatic PAP
(APAP) devices, Bi-level PAP devices (BPAP) devices. Resuscitators are
classified as manual and gas powered resuscitators. Ventilators are further
segmented into non invasive and invasive ventilators. Inhalers are segmented
such as dry powdered inhaler and metered dose inhaler. Monitoring device market
is segmented into Pulse Oximeters, Capnographs and Gas Analyzers. Pulse
Oximeters are further classified into Finger Pulse Oximeters, Handheld Pulse
Oximeters, Wrist Pulse Oximeters, and Tabletop Pulse Oximeters. Diagnostic
segments are divided into Spirometers, Peak Flow Meters, Polysomnographs device
(PSG), where in Spirometers are further classified into Volumetric Spirometers
and Flow Measuring Spirometers. PSG devices are classified into Clinical
Polysomnographs devices and Ambulatory Polysomnographs devices. Consumables are
divided into masks, tracheostomy tubes, nasal cannulas and others. Masks are
segmented into Nasal masks, Full face masks, Nasal pillow masks, and Oral masks
and others which include Non rebreather masks and Pocket masks.
Request a sample report @ https://www.wiseguyreports.com/sample-request/591163-respiratory-care-devices-global-market-forecast-to-2022
By application, the Respiratory Care Device markets are divided into Acute Respiratory distress syndrome, asthma, Chronic Obstructive pulmonary diseases, Pulmonary fibrosis, Cystic fibrosis, Pneumonia, Respiratory failure, Restrictive lung diseases, Sleep Apnea and Tuberculosis, Lung Cancer and Others. Chronic Obstructive pulmonary diseases are further divided into chronic bronchitis and emphysema. Based on the end- users they are segmented into hospitals and home healthcare.
Among the Respiratory Care Devices products, therapeutic devices market dominated the products market by occupying a largest share as well as fastest growing segment from 2015 to 2022. In applications, the asthma is the largest market share and COPD is the fastest growing segment from 2015 to 2022. By end- users, hospitals is the largest segment with a share of 52.4% and, home care is the fastest segment with a CAGR from 2015 to 2022.Geographical wise, North America is the largest market, with a share of 45.2% followed by Europe and Asia. The APAC region is the fastest growing region from 2015 to 2022 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the Respiratory Care Device market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The Respiratory Care Device market is expected to grow steadily at a high single digit CAGR from 2015 to 2022. The factors driving the growth of this market are increasing incidences of respiratory diseases such as Respiratory failure, COPD, asthma, sleep apnea, cystic fibrosis, Pneumonia, Tuberculosis etc. Urbanization and increasing pollution is one of the factor driving the respiratory care device market, new technology products boosting respiratory care device products market growth, increase in aging population, Increasing prevalence of tobacco usage, Increasing preterm birth incidence, rising use of non invasive ventilators and government initiatives and wide range of available products likely to propel the respiratory care device market. In addition to this, Growing Demand for Home Care Therapeutic Devices, Huge Pool of Undiagnosed Sleep Apnea Patients, Increasing COPD, leading to increasing the requirement of ventilators, healthy growth in the innovative products and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market. However, Lack of awareness of the disease, Large Under diagnosed and Undertreated Population, Harmful Effects of Certain Devices on Neonates and reluctance in adoption of new technologies are hampering the growth of the market. The threats for the respiratory care device market include Availability of low cost products from local manufacturers, stringent regulations for approval and mandatory licensing for Practitioners and Reimbursement issues.
The Respiratory Care Device global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the respiratory care device market are Becton Dickinson and Company (Care Fusion) (U.S.), Chart Industries (U.S.), Drager Medical AG & Co. KGaA (Germany), Fisher & Paykel Healthcare (New Zealand), GE Healthcare (U.K.), Invacare Corporation (U.S.), Gettinge Groups (Sweden), Medtronic PLC (Ireland), Philips Healthcare (Netherlands) and Resmed, Inc. (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
Make an enquiry before buying this
Report @ https://www.wiseguyreports.com/enquiry/591163-respiratory-care-devices-global-market-forecast-to-2022
Table of content
1 EXECUTIVE SUMMARY
27
2 INTRODUCTION 35
2.1 KEY TAKE AWAYS 35
2.2 REPORT DESCRIPTION 35
2.3 MARKETS COVERED 38
2.4 STAKEHOLDERS 41
2.5 RESEARCH METHODOLOGY 41
2.5.1 MARKET SIZE ESTIMATION 43
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 45
2.5.3 SECONDARY SOURCES 46
2.5.4 PRIMARY SOURCES 47
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 47
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 48
2.5.7 ASSUMPTIONS 48
3 MARKET ANALYSIS 50
3.1 INTRODUCTION 50
3.2 MARKET SEGMENTATION 51
3.3 FACTORS INFLUENCING MARKET 53
3.3.1 DRIVERS AND OPPORTUNITIES 53
3.3.1.1 Rising incidences of respiratory diseases 53
3.3.1.2 Urbanization and increasing pollution 54
3.3.1.3 Increasing prevalence of tobacco usage 55
3.3.1.4 Increasing preterm birth incidence 56
3.3.1.5 Rising use of non invasive ventilators 57
3.3.1.6 Growing demand for home care therapeutic devices 57
3.3.1.7 Huge pool of undiagnosed sleep apnea patients 58
3.3.1.8 Increasing COPD, leading to increasing the requirement of respiratory care therapy 59
3.3.2 RESTRAINTS AND THREATS 59
3.3.2.1 Lack of awareness of the disease 59
3.3.2.2 Large Under diagnosed and Undertreated Population 61
3.3.2.3 Harmful effects of certain devices on neonates 62
3.3.2.4 Availability of low cost products from local manufacturers 63
3.3.2.5 Stringent regulations for approval and mandatory licensing for
respiratory therapist 64
3.3.2.6 Reimbursement issues 65
3.4 REGULATORY AFFAIRS 65
3.4.1 U.S. 66
3.4.2 EUROPE 66
3.4.3 INDIA 67
3.4.4 CHINA 68
3.4.5 JAPAN 69
3.5 REIMBURSEMENT 69
3.6 SUPPLY CHAIN ANALYSIS 72
3.7 TECHNOLOGICAL ADVANCEMENTS 75
3.7.1 DUBBED COUGHAWARE FROM QUVIUM & DSP CONCEPTS 75
3.7.2 CHEST WALL MOTION ASSESSMENT SYSTEM FROM UNIVERSITY OF WARWICK 75
3.7.3 THE HEALTH AND ENVIRONMENTAL TRACKER (HET), A WEARABLE SYSTEM OF NANO-ENABLED SENSORS BY RESEARCHERS FROM NORTH CAROLINA STATE UNIVERSITY'S (NCSU) 75
3.7.4 SMART INHALERS 76
3.7.5 SMART NEBULIZERS 76
3.7.6 MASIMO CORPORATION’S RADIUS-7 FDA 510(K) CLEARANCE 77
3.7.7 NONIN MEDICALS (U.S.) LAUNCHED A SMART WIRELESS FINGER PULSE OXIMETER 77
3.7.8 SMARTDOSE MINI OXYGEN CONSERVER BY DRIVE DEVILBISS 77
3.7.9 MICRO-CPAP MACHINE 77
3.8 PORTER’S FIVE FORCE ANALYSIS 78
3.8.1 THREAT OF NEW ENTRANTS 78
3.8.2 THREAT OF SUBSTITUTES 79
3.8.3 BARGAINING POWER OF SUPPLIERS 80
3.8.4 BARGAINING POWER OF BUYERS 81
3.8.5 COMPETITIVE RIVALRY 81
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 82
3.10 PATENT ANALYSIS BY MAJOR PLAYERS 85
4 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY PRODUCTS 88
4.1 INTRODUCTION 88
4.2 THERAPEUTICS DEVICES 91
4.2.1 HUMIDIFIERS 95
4.2.1.1 Active Humidifiers 98
4.2.1.2 Passive Humidifiers 101
4.2.2 NEBULIZERS 103
4.2.2.1 Jet Nebulizer 107
4.2.2.2 Ultrasonic Nebulizer 109
4.2.2.3 Mesh Nebulizer 111
4.2.2.4 Smart Nebulizers 112
4.2.3 OXYGEN CONCENTRATORS 113
4.2.3.1 Stationary Oxygen Concentrators 117
4.2.3.2 Portable Oxygen Concentrators 119
4.2.4 POSITIVE AIRWAY PRESSURE DEVICES (PAP) 121
4.2.4.1 Continuous PAPDevices (CPAP) 125
4.2.4.2 Automatic PAP (APAP) Devices 128
4.2.4.3 Bi-Level PAP (BPAP) Devices 130
4.2.5 RESUSCITATORS 132
4.2.5.1 Manual Resuscitator 135
4.2.5.2 Gas Powdered Resuscitator 137
4.2.6 VENTILATORS 139
4.2.6.1 Non-Invasive Ventilators 142
4.2.6.2 Invasive Ventilators 144
4.2.7 INHALERS 146
4.2.7.1 Dry Powder Inhalers 149
4.2.7.2 Metered Dose Inhaler 150
4.2.8 OTHERS 152
4.2.8.1 Positive Expiratory Pressure Device (PEP) 154
4.2.8.2 Nitric Oxide Delivery Unit 154
4.2.8.3 Oxygen Hood 155
4.2.8.4 Flutter Valve Device 156
4.2.8.5 Nasal Cornet 156
4.2.8.6 Intrapulmonary Percussive Ventilator 157
4.2.8.7 Cardiopulmonary Resuscitation Emergency Kit 157
4.2.8.8 High Frequency Chest Wall Oscillation Device (HFCWO) 158
4.2.8.9 Diaphragm Pacing 158
4.3 MONITORING DEVICES 159
4.3.1 PULSE OXIMETERS 162
4.3.1.1 Finger Pulse Oximeters 166
4.3.1.2 Handheld Pulse Oximeters 168
4.3.1.3 Wrist Pulse Oximeters 170
4.3.1.4 Tabletop Pulse Oximeters 172
4.3.2 CAPNOGRAPHS 174
4.3.3 GAS ANALYZERS 175
4.4 DIAGNOSTIC DEVICES 177
4.4.1 SPIROMETERS 181
4.4.1.1 Volumetric Spirometers 185
4.4.1.2 Flow Measuring Spirometers 187
4.4.2 PEAK FLOW METERS 188
4.4.3 POLYSOMNOGRAPH DEVICES (PSG) 191
4.4.3.1 Clinical Polysomnograph Devices 193
4.4.3.2 Ambulatory Polysomnographs Devices 195
4.5 CONSUMABLES 197
4.5.1 MASKS 200
4.5.1.1 Nasal Masks 202
4.5.1.2 Full Face Mask 203
4.5.1.3 Nasal Pillow Masks 205
4.5.1.4 Nasal Oral Masks 206
4.5.1.5 OTHERS 207
4.5.2 TRACHEOSTOMY TUBE 209
4.5.3 NASAL CANNULAS 211
4.6 OTHERS 214
5 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY APPLICATIONS 217
5.1 INTRODUCTION 217
5.2 ACUTE RESPIRATORY DISTRESS SYNDROME 219
5.3 ASTHMA 221
5.4 CHRONIC OBSTRUCTIVE PULMANARY DISEASE (COPD) 224
5.4.1 CHRONIC BRONCHITIS 226
5.4.2 EMPHYSEMA 228
5.5 CYSTIC FIBROSIS 229
5.6 PULMONARY FIBROSIS 231
5.7 PNEUMONIA 233
5.8 RESPIRATORY FAILURE 236
5.9 SLEEP APNEA 239
5.10 TUBERCULOSIS 242
5.11 LUNG CANCER 243
5.12 OTHERS 245
6 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY END-USERS 247
6.1 INTRODUCTION 247
6.2 HOSPITALS 249
6.3 HOME HEALTH CARE 251
7 REGIONAL MARKET ANALYSIS 254
7.1 INTRODUCTION 254
7.2 NORTH AMERICA 257
7.2.1 U.S. 258
7.2.2 EUROPE 277
7.2.3 ASIA PACIFIC 298
7.2.4 REST OF THE WORLD 317
8 COMPANY DEVELOPMENTS 338
8.1 INTRODUCTION 338
8.1.1 NEW PRODUCT LAUNCH AS MAJOR GROWTH STRATEGY OF RESPIRATORY CARE DEVICE MARKET PLAYERS 339
8.2 NEW PRODUCT LAUNCH 339
8.3 MERGERS AND ACQUISITION 344
8.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES 347
8.5 APPROVAL 350
8.6 OTHERS 352
9 MAJOR PLAYERS PROFILES 354
9.1 BECTON, DICKINSON AND COMPANY (CAREFUSION CORPORATION) 354
9.1.1 OVERVIEW 354
9.1.2 FINANCIALS 355
9.1.3 PRODUCT PORTFOLIO 358
9.1.4 KEY DEVELOPMENTS 360
9.1.5 BUSINESS STRATEGY 361
9.1.6 SWOT ANALYSIS 362
9.2 CHART INDUSTRIES, INC. 363
9.2.1 OVERVIEW 363
9.2.2 FINANCIALS 364
9.2.3 PRODUCT PORTFOLIO 366
9.2.4 KEY DEVELOPMENTS 367
9.2.5 BUSINESS STRATEGY 367
9.2.6 SWOT ANALYSIS 368
9.3 DRAGER MEDICAL AG & CO. KGAA 369
9.3.1 OVERVIEW 369
9.3.2 FINANCIALS 370
9.3.3 PRODUCT PORTFOLIO 373
9.3.4 KEY DEVELOPMENTS 374
9.3.5 BUSINESS STRATEGY 374
9.3.6 SWOT ANALYSIS 375
9.4 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED 376
9.4.1 OVERVIEW 376
9.4.2 FINANCIALS 377
9.4.3 PRODUCT PORTFOLIO 379
9.4.4 KEY DEVELOPMENTS 383
9.4.5 BUSINESS STRATEGY 383
9.4.6 SWOT ANALYSIS 385
9.5 GE HEALTHCARE 386
9.5.1 OVERVIEW 386
9.5.2 FINANCIALS 387
9.5.3 PRODUCT PORTFOLIO 390
9.5.4 KEY DEVELOPMENTS 390
9.5.5 BUSINESS STRATEGY 391
9.5.6 SWOT ANALYSIS 392
9.6 GETINGE GROUPS (MAQUET GMBH & CO. KG) 393
9.6.1 OVERVIEW 393
9.6.2 FINANCIALS 394
9.6.3 PRODUCT PORTFOLIO 395
9.6.4 KEY DEVELOPMENTS 396
9.6.5 BUSINESS STRATEGY 396
9.6.6 SWOT ANALYSIS 397
9.7 INVACARE CORPORATION 398
9.7.1 OVERVIEW 398
9.7.2 FINANCIALS 399
9.7.3 PRODUCT PORTFOLIO 402
9.7.4 KEY DEVELOPMENTS 405
9.7.5 BUSINESS STRATEGY 405
9.7.6 SWOT ANALYSIS 406
9.8 MEDTRONIC INC. 407
9.8.1 OVERVIEW 407
9.8.2 FINANCIALS 408
9.8.3 PRODUCT PORTFOLIO 410
9.8.4 KEY DEVELOPMENTS 413
9.8.5 BUSINESS STRATEGY 415
9.8.6 SWOT ANALYSIS 416
9.9 PHILIPS HEALTHCARE 417
9.9.1 OVERVIEW 417
9.9.2 FINANCIALS 418
9.9.3 PRODUCT PORTFOLIO 421
9.9.4 KEY DEVELOPMENTS 423
9.9.5 BUSINESS STRATEGY 425
9.9.6 SWOT ANALYSIS 426
9.10 RESMED CORP 427
9.10.1 OVERVIEW 427
9.10.2 FINANCIALS 428
9.10.3 PRODUCT PORTFOLIO 429
9.10.4 KEY DEVELOPMENTS 432
9.10.5 BUSINESS STRATEGY 434
9.10.6 SWOT ANALYSIS 435
2 INTRODUCTION 35
2.1 KEY TAKE AWAYS 35
2.2 REPORT DESCRIPTION 35
2.3 MARKETS COVERED 38
2.4 STAKEHOLDERS 41
2.5 RESEARCH METHODOLOGY 41
2.5.1 MARKET SIZE ESTIMATION 43
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 45
2.5.3 SECONDARY SOURCES 46
2.5.4 PRIMARY SOURCES 47
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 47
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 48
2.5.7 ASSUMPTIONS 48
3 MARKET ANALYSIS 50
3.1 INTRODUCTION 50
3.2 MARKET SEGMENTATION 51
3.3 FACTORS INFLUENCING MARKET 53
3.3.1 DRIVERS AND OPPORTUNITIES 53
3.3.1.1 Rising incidences of respiratory diseases 53
3.3.1.2 Urbanization and increasing pollution 54
3.3.1.3 Increasing prevalence of tobacco usage 55
3.3.1.4 Increasing preterm birth incidence 56
3.3.1.5 Rising use of non invasive ventilators 57
3.3.1.6 Growing demand for home care therapeutic devices 57
3.3.1.7 Huge pool of undiagnosed sleep apnea patients 58
3.3.1.8 Increasing COPD, leading to increasing the requirement of respiratory care therapy 59
3.3.2 RESTRAINTS AND THREATS 59
3.3.2.1 Lack of awareness of the disease 59
3.3.2.2 Large Under diagnosed and Undertreated Population 61
3.3.2.3 Harmful effects of certain devices on neonates 62
3.3.2.4 Availability of low cost products from local manufacturers 63
3.3.2.5 Stringent regulations for approval and mandatory licensing for
respiratory therapist 64
3.3.2.6 Reimbursement issues 65
3.4 REGULATORY AFFAIRS 65
3.4.1 U.S. 66
3.4.2 EUROPE 66
3.4.3 INDIA 67
3.4.4 CHINA 68
3.4.5 JAPAN 69
3.5 REIMBURSEMENT 69
3.6 SUPPLY CHAIN ANALYSIS 72
3.7 TECHNOLOGICAL ADVANCEMENTS 75
3.7.1 DUBBED COUGHAWARE FROM QUVIUM & DSP CONCEPTS 75
3.7.2 CHEST WALL MOTION ASSESSMENT SYSTEM FROM UNIVERSITY OF WARWICK 75
3.7.3 THE HEALTH AND ENVIRONMENTAL TRACKER (HET), A WEARABLE SYSTEM OF NANO-ENABLED SENSORS BY RESEARCHERS FROM NORTH CAROLINA STATE UNIVERSITY'S (NCSU) 75
3.7.4 SMART INHALERS 76
3.7.5 SMART NEBULIZERS 76
3.7.6 MASIMO CORPORATION’S RADIUS-7 FDA 510(K) CLEARANCE 77
3.7.7 NONIN MEDICALS (U.S.) LAUNCHED A SMART WIRELESS FINGER PULSE OXIMETER 77
3.7.8 SMARTDOSE MINI OXYGEN CONSERVER BY DRIVE DEVILBISS 77
3.7.9 MICRO-CPAP MACHINE 77
3.8 PORTER’S FIVE FORCE ANALYSIS 78
3.8.1 THREAT OF NEW ENTRANTS 78
3.8.2 THREAT OF SUBSTITUTES 79
3.8.3 BARGAINING POWER OF SUPPLIERS 80
3.8.4 BARGAINING POWER OF BUYERS 81
3.8.5 COMPETITIVE RIVALRY 81
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 82
3.10 PATENT ANALYSIS BY MAJOR PLAYERS 85
4 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY PRODUCTS 88
4.1 INTRODUCTION 88
4.2 THERAPEUTICS DEVICES 91
4.2.1 HUMIDIFIERS 95
4.2.1.1 Active Humidifiers 98
4.2.1.2 Passive Humidifiers 101
4.2.2 NEBULIZERS 103
4.2.2.1 Jet Nebulizer 107
4.2.2.2 Ultrasonic Nebulizer 109
4.2.2.3 Mesh Nebulizer 111
4.2.2.4 Smart Nebulizers 112
4.2.3 OXYGEN CONCENTRATORS 113
4.2.3.1 Stationary Oxygen Concentrators 117
4.2.3.2 Portable Oxygen Concentrators 119
4.2.4 POSITIVE AIRWAY PRESSURE DEVICES (PAP) 121
4.2.4.1 Continuous PAPDevices (CPAP) 125
4.2.4.2 Automatic PAP (APAP) Devices 128
4.2.4.3 Bi-Level PAP (BPAP) Devices 130
4.2.5 RESUSCITATORS 132
4.2.5.1 Manual Resuscitator 135
4.2.5.2 Gas Powdered Resuscitator 137
4.2.6 VENTILATORS 139
4.2.6.1 Non-Invasive Ventilators 142
4.2.6.2 Invasive Ventilators 144
4.2.7 INHALERS 146
4.2.7.1 Dry Powder Inhalers 149
4.2.7.2 Metered Dose Inhaler 150
4.2.8 OTHERS 152
4.2.8.1 Positive Expiratory Pressure Device (PEP) 154
4.2.8.2 Nitric Oxide Delivery Unit 154
4.2.8.3 Oxygen Hood 155
4.2.8.4 Flutter Valve Device 156
4.2.8.5 Nasal Cornet 156
4.2.8.6 Intrapulmonary Percussive Ventilator 157
4.2.8.7 Cardiopulmonary Resuscitation Emergency Kit 157
4.2.8.8 High Frequency Chest Wall Oscillation Device (HFCWO) 158
4.2.8.9 Diaphragm Pacing 158
4.3 MONITORING DEVICES 159
4.3.1 PULSE OXIMETERS 162
4.3.1.1 Finger Pulse Oximeters 166
4.3.1.2 Handheld Pulse Oximeters 168
4.3.1.3 Wrist Pulse Oximeters 170
4.3.1.4 Tabletop Pulse Oximeters 172
4.3.2 CAPNOGRAPHS 174
4.3.3 GAS ANALYZERS 175
4.4 DIAGNOSTIC DEVICES 177
4.4.1 SPIROMETERS 181
4.4.1.1 Volumetric Spirometers 185
4.4.1.2 Flow Measuring Spirometers 187
4.4.2 PEAK FLOW METERS 188
4.4.3 POLYSOMNOGRAPH DEVICES (PSG) 191
4.4.3.1 Clinical Polysomnograph Devices 193
4.4.3.2 Ambulatory Polysomnographs Devices 195
4.5 CONSUMABLES 197
4.5.1 MASKS 200
4.5.1.1 Nasal Masks 202
4.5.1.2 Full Face Mask 203
4.5.1.3 Nasal Pillow Masks 205
4.5.1.4 Nasal Oral Masks 206
4.5.1.5 OTHERS 207
4.5.2 TRACHEOSTOMY TUBE 209
4.5.3 NASAL CANNULAS 211
4.6 OTHERS 214
5 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY APPLICATIONS 217
5.1 INTRODUCTION 217
5.2 ACUTE RESPIRATORY DISTRESS SYNDROME 219
5.3 ASTHMA 221
5.4 CHRONIC OBSTRUCTIVE PULMANARY DISEASE (COPD) 224
5.4.1 CHRONIC BRONCHITIS 226
5.4.2 EMPHYSEMA 228
5.5 CYSTIC FIBROSIS 229
5.6 PULMONARY FIBROSIS 231
5.7 PNEUMONIA 233
5.8 RESPIRATORY FAILURE 236
5.9 SLEEP APNEA 239
5.10 TUBERCULOSIS 242
5.11 LUNG CANCER 243
5.12 OTHERS 245
6 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY END-USERS 247
6.1 INTRODUCTION 247
6.2 HOSPITALS 249
6.3 HOME HEALTH CARE 251
7 REGIONAL MARKET ANALYSIS 254
7.1 INTRODUCTION 254
7.2 NORTH AMERICA 257
7.2.1 U.S. 258
7.2.2 EUROPE 277
7.2.3 ASIA PACIFIC 298
7.2.4 REST OF THE WORLD 317
8 COMPANY DEVELOPMENTS 338
8.1 INTRODUCTION 338
8.1.1 NEW PRODUCT LAUNCH AS MAJOR GROWTH STRATEGY OF RESPIRATORY CARE DEVICE MARKET PLAYERS 339
8.2 NEW PRODUCT LAUNCH 339
8.3 MERGERS AND ACQUISITION 344
8.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS & JOINT VENTURES 347
8.5 APPROVAL 350
8.6 OTHERS 352
9 MAJOR PLAYERS PROFILES 354
9.1 BECTON, DICKINSON AND COMPANY (CAREFUSION CORPORATION) 354
9.1.1 OVERVIEW 354
9.1.2 FINANCIALS 355
9.1.3 PRODUCT PORTFOLIO 358
9.1.4 KEY DEVELOPMENTS 360
9.1.5 BUSINESS STRATEGY 361
9.1.6 SWOT ANALYSIS 362
9.2 CHART INDUSTRIES, INC. 363
9.2.1 OVERVIEW 363
9.2.2 FINANCIALS 364
9.2.3 PRODUCT PORTFOLIO 366
9.2.4 KEY DEVELOPMENTS 367
9.2.5 BUSINESS STRATEGY 367
9.2.6 SWOT ANALYSIS 368
9.3 DRAGER MEDICAL AG & CO. KGAA 369
9.3.1 OVERVIEW 369
9.3.2 FINANCIALS 370
9.3.3 PRODUCT PORTFOLIO 373
9.3.4 KEY DEVELOPMENTS 374
9.3.5 BUSINESS STRATEGY 374
9.3.6 SWOT ANALYSIS 375
9.4 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED 376
9.4.1 OVERVIEW 376
9.4.2 FINANCIALS 377
9.4.3 PRODUCT PORTFOLIO 379
9.4.4 KEY DEVELOPMENTS 383
9.4.5 BUSINESS STRATEGY 383
9.4.6 SWOT ANALYSIS 385
9.5 GE HEALTHCARE 386
9.5.1 OVERVIEW 386
9.5.2 FINANCIALS 387
9.5.3 PRODUCT PORTFOLIO 390
9.5.4 KEY DEVELOPMENTS 390
9.5.5 BUSINESS STRATEGY 391
9.5.6 SWOT ANALYSIS 392
9.6 GETINGE GROUPS (MAQUET GMBH & CO. KG) 393
9.6.1 OVERVIEW 393
9.6.2 FINANCIALS 394
9.6.3 PRODUCT PORTFOLIO 395
9.6.4 KEY DEVELOPMENTS 396
9.6.5 BUSINESS STRATEGY 396
9.6.6 SWOT ANALYSIS 397
9.7 INVACARE CORPORATION 398
9.7.1 OVERVIEW 398
9.7.2 FINANCIALS 399
9.7.3 PRODUCT PORTFOLIO 402
9.7.4 KEY DEVELOPMENTS 405
9.7.5 BUSINESS STRATEGY 405
9.7.6 SWOT ANALYSIS 406
9.8 MEDTRONIC INC. 407
9.8.1 OVERVIEW 407
9.8.2 FINANCIALS 408
9.8.3 PRODUCT PORTFOLIO 410
9.8.4 KEY DEVELOPMENTS 413
9.8.5 BUSINESS STRATEGY 415
9.8.6 SWOT ANALYSIS 416
9.9 PHILIPS HEALTHCARE 417
9.9.1 OVERVIEW 417
9.9.2 FINANCIALS 418
9.9.3 PRODUCT PORTFOLIO 421
9.9.4 KEY DEVELOPMENTS 423
9.9.5 BUSINESS STRATEGY 425
9.9.6 SWOT ANALYSIS 426
9.10 RESMED CORP 427
9.10.1 OVERVIEW 427
9.10.2 FINANCIALS 428
9.10.3 PRODUCT PORTFOLIO 429
9.10.4 KEY DEVELOPMENTS 432
9.10.5 BUSINESS STRATEGY 434
9.10.6 SWOT ANALYSIS 435
Purchase a 1-User License Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=591163
Contact for More Information at sales@wiseguyreports.com or +1
(646) 845 9349 (US) and +44 208 133
9349 (UK)
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt.
Ltd. and offers premium progressive statistical surveying, market research
reports, analysis & forecast data for industries and governments around the
globe. We also provide COTS (Commercial off the Shelf) business sector reports
as custom exploration agreeing your particular needs.
No comments:
Post a Comment